These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 17634512)
1. Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies. Ferbas J; Thomas J; Hodgson J; Gaur A; Casadevall N; Swanson SJ Clin Vaccine Immunol; 2007 Sep; 14(9):1165-72. PubMed ID: 17634512 [TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C. Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778 [TBL] [Abstract][Full Text] [Related]
3. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847 [TBL] [Abstract][Full Text] [Related]
4. The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum. Mytych DT; La S; Barger T; Ferbas J; Swanson SJ J Pharm Biomed Anal; 2009 Feb; 49(2):415-26. PubMed ID: 19135328 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers. Wu G; Wadgymar A; Wong G; Ting R; Nathoo B; Mendelssohn D; Pandeya S; Sapir D; Tam P Am J Kidney Dis; 2004 Aug; 44(2):264-9. PubMed ID: 15264184 [TBL] [Abstract][Full Text] [Related]
6. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients]. Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943 [TBL] [Abstract][Full Text] [Related]
7. Pure red cell aplasia with anti-erythropoietin antibodies occurs more commonly with one formulation of epoetin alfa than another. Macdougall IC Curr Med Res Opin; 2004 Jan; 20(1):83-6. PubMed ID: 14741076 [TBL] [Abstract][Full Text] [Related]
8. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin. Casadevall N Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000 [TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience. Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P; J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241 [TBL] [Abstract][Full Text] [Related]
10. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS). Macdougall IC; Casadevall N; Locatelli F; Combe C; London GM; Di Paolo S; Kribben A; Fliser D; Messner H; McNeil J; Stevens P; Santoro A; De Francisco AL; Percheson P; Potamianou A; Foucher A; Fife D; Mérit V; Vercammen E; Nephrol Dial Transplant; 2015 Mar; 30(3):451-60. PubMed ID: 25239637 [TBL] [Abstract][Full Text] [Related]
14. Measurement of anti-erythropoiesis-stimulating agent IgG4 antibody as an indicator of antibody-mediated pure red cell aplasia. Weeraratne DK; Kuck AJ; Chirmule N; Mytych DT Clin Vaccine Immunol; 2013 Jan; 20(1):46-51. PubMed ID: 23114696 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia. Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Bennett CL; Cournoyer D; Carson KR; Rossert J; Luminari S; Evens AM; Locatelli F; Belknap SM; McKoy JM; Lyons EA; Kim B; Sharma R; Costello S; Toffelmire EB; Wells GA; Messner HA; Yarnold PR; Trifilio SM; Raisch DW; Kuzel TM; Nissenson A; Lim LC; Tallman MS; Casadevall N Blood; 2005 Nov; 106(10):3343-7. PubMed ID: 16099877 [TBL] [Abstract][Full Text] [Related]
17. Pure red-cell aplasia caused by the antibody to recombinant erythropoietin, epoetin-beta, in a Japanese patient with chronic renal failure. Shinohara K; Mitani N; Miyazaki M; Sakuragi S; Matsuda K; Ogawara S; Saito T; Kaneoka H; Ooji T Am J Hematol; 2005 Jan; 78(1):15-20. PubMed ID: 15609276 [TBL] [Abstract][Full Text] [Related]